首页 | 本学科首页   官方微博 | 高级检索  
   检索      


The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells
Institution:1. Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA;2. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA;3. Preclinical Therapeutics Core, University of California San Francisco, San Francisco, CA 94158, USA;4. Department of Urology, University of California, San Francisco, San Francisco, CA 94143, USA;5. Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA 94143, USA;6. Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA;7. Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143, USA
Abstract:
Keywords:AR-V7  Indisulam  Alternative splicing  RBM39  Prostate cancer  Androgen receptor
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号